SCHEMBL25885262

SCHEMBL25885262

O=Cc1cc(Br)c(OCc2ccccc2)c(OC(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.46
▸ MAPT P10636 5/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ LMNA P02545 3/20 0.46
▸ HTT P42858 1/20 0.46
▸ MAOA P21397 2/20 0.44
▸ MAOB P27338 2/20 0.44
▸ APP P05067 1/20 0.44
▸ THRA P10827 2/20 0.43
▸ THRB P10828 2/20 0.43
▸ RXRA P19793 1/20 0.42
▸ RXRB P28702 1/20 0.42
▸ RXRG P48443 1/20 0.42
▸ SMN1; SMN2 Q16637 5/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ MEN1 O00255 3/20 0.40
▸ CYP1A2 P05177 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25885264 0.85 RXRA (0.45) ALDH1A1MAPTLMNAMAOAMAOB
SCHEMBL3955227 0.84 THRA (0.57) ALDH1A1MAPTKMT2ALMNAHTT
SCHEMBL3961650 0.83 APP (0.59) ALDH1A1MAPTKMT2ALMNAHTT
SCHEMBL3954569 0.79 RXRA (0.52) ALDH1A1MAPTKMT2ALMNAHTT
SCHEMBL20139466 0.78 MAOA (0.49) ALDH1A1MAPTKMT2ALMNAHTT
SCHEMBL5365873 0.77 MAOA (0.46) ALDH1A1MAPTKMT2ALMNAHTT
SCHEMBL4045055 0.76 MAOA (0.57) ALDH1A1MAPTLMNAMAOAMAOB
SCHEMBL31528101 0.75 MAOB (0.55) ALDH1A1MAPTLMNAHTTMAOA
SCHEMBL9099618 0.75 SIRT1 (0.61) ALDH1A1MAPTKMT2ALMNAHTT
SCHEMBL18002600 0.75 MAOA (0.60) ALDH1A1KMT2AMAOAMAOBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234943-A1 TREX1 INHIBITORS AND USES THEREOF TEMPEST THERAPEUTICS, INC. 2023-07-27 — — US disclosed
US-20230234943-A1 TREX1 INHIBITORS AND USES THEREOF TEMPEST THERAPEUTICS, INC. 2023-07-27 — — US disclosed
WO-2021263079-A1 TREX1 INHIBITORS AND USES THEREOF TEMPEST THERAPEUTICS, INC. (US) 2021-12-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234943-A1 TREX1 INHIBITORS AND USES THEREOF FEN1, ERCC4, DCLRE1B ALDH1A1 1451/4885MAPT 3694/4885KMT2A 3032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback